The Incidence of Malignant Tumours in Patients with Respiratory Sarcoidosis
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visithttps://creativecommons.org/licenses/by/4.0/.
Abstract
During the period 1962-71 a total of 2544 patients with respiratory sarcoidosis were reported to the Danish Institute of Clinical Epidemiology. Among them 48 patients developed a malignant tumour, the follow-up period ending on 31 December 1971. Only 33·8 cases of cancer were expected if sarcoidosis patients had had the same rates as the general population; the difference between the expected and observed number is statistically significant (0·02 >P > 0·01). Malignant lymphomata occurred 11 times and lung cancer 3 times more frequently than expected. For all other forms of cancer taken together, there was no significant difference between the expected and the observed number of cases.
The increased cancer incidence may result from immunological deficiencies in patients with sarcoidosis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alsbirk P. H. Epidemiologic studies on sarcoidosis in Denmark based on a nation-wide central register. A preliminary report. Acta Med Scand Suppl. 1964;425:106–109. doi: 10.1111/j.0954-6820.1964.tb05713.x. [DOI] [PubMed] [Google Scholar]
- Brincker H. Sarcoid reactions and sarcoidosis in Hodgkin's disease and other malignant lymphomata. Br J Cancer. 1972 Apr;26(2):120–123. doi: 10.1038/bjc.1972.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chase M. W. Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis. Cancer Res. 1966 Jun;26(6):1097–1120. [PubMed] [Google Scholar]
- Doll R., Kinlen L. Immunosurveillance and cancer: epidemiological evidence. Br Med J. 1970 Nov 14;4(5732):420–422. doi: 10.1136/bmj.4.5732.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horwitz O., Payne P. G., Wilbek E. Epidemiology of sarcoidosis in Denmark. Dan Med Bull. 1967 Jun;14(7):178–182. [PubMed] [Google Scholar]
- Keast D. Immunosurveillance and cancer. Lancet. 1970 Oct 3;2(7675):710–712. doi: 10.1016/s0140-6736(70)91973-2. [DOI] [PubMed] [Google Scholar]
- Romer F., Paulsen S., Antonius V., Lanng Nielsen J., Hommelgaard P. Sarcoidosis in a Danish "amt". A retrospective epidemiologic study of sarcoidosis in Ringkobing Amt from 1960 to 1969. Dan Med Bull. 1973 Aug;20(4):112–120. [PubMed] [Google Scholar]